Blood-brain barrier genomics, proteomics, and new transporter discovery.
The blood-brain barrier (BBB) is an impermeable cellular interface that physically separates the blood from the interstices of the brain. The endothelial cells lining the brain blood vessels form the principle barrier, and their unique phenotype is a consequence of dynamic interactions with several perivascular cell types present in the brain parenchyma. In addition, BBB dysfunction has been observed in the large majority of neurological diseases, but the causes of aberrant vascular behavior are generally unknown. Because of its barrier phenotype, drug delivery to the brain has also proven to be a very difficult task. Global genomics and proteomics analyses are currently being used to examine BBB function in healthy and diseased brain to better characterize this dynamic interface. It is becoming increasingly evident that these approaches have the potential to clarify the unique attributes of a healthy BBB, to identify therapeutic targets in diseased brain, and to identify novel conduits for noninvasive delivery of drugs against these targets. This review will discuss the application of genomics and proteomics to blood-brain barrier research and will offer views on the prospects of such approaches.
Shusta
Eric V
EV
Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA. shusta@engr.wisc.edu
D000818:Animals; D001812:Blood-Brain Barrier / Q000502:physiology*; D002352:Carrier Proteins / Q000378:metabolism*; D023281:Genomics; D006801:Humans; D009422:Nervous System Diseases / Q000628:therapy; D040901:Proteomics
D002352:Carrier Proteins
Mol Cancer. 2003 Jul 09;2:25
12904264
Physiol Genomics. 2003 Sep 29;15(1):75-83
12902546
J Cereb Blood Flow Metab. 2006 Jul;26(7):959-73
16306934
J Biol Chem. 2003 Oct 31;278(44):43489-95
12923172
Brain Res. 2001 Aug 10;910(1-2):106-15
11489260
Life Sci. 2004 Feb 27;74(15):1899-909
14761671
J Biol Chem. 2002 May 3;277(18):16294-303
11847224
Virology. 1987 Oct;160(2):523-6
3660593
J Clin Invest. 2003 Sep;112(5):736-44
12952922
Electrophoresis. 1997 Mar-Apr;18(3-4):533-7
9150937
Adv Drug Deliv Rev. 2001 Jul 28;49(3):223-35
11551396
Neuroreport. 2003 Oct 6;14(14):1861-5
14534436
J Cereb Blood Flow Metab. 2002 Nov;22(11):1319-26
12439289
In Vitro Cell Dev Biol Anim. 2003 Jul-Aug;39(7):313-20
14613336
Cancer Res. 2003 Oct 15;63(20):6613-25
14583454
J Neurochem. 1991 Dec;57(6):2136-9
1940920
J Biol Chem. 1998 Nov 6;273(45):29635-40
9792673
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6025-30
8650213
Int J Cancer. 2004 Mar 20;109(2):214-9
14750172
J Virol. 1998 Apr;72(4):2905-16
9525611
FASEB J. 2003 Nov;17(14):2085-7
12958161
J Clin Invest. 1998 Jun 1;101(11):2550-8
9616226
Mol Cell Proteomics. 2002 Jan;1(1):75-82
12096143
Genomics. 2000 Aug 15;68(1):41-56
10950925
Mol Cell Biol. 1999 Mar;19(3):1720-30
10022859
Brain Res Mol Brain Res. 2003 Jul 23;115(2):130-46
12877984
Science. 1995 Oct 20;270(5235):467-70
7569999
Mol Cell Biol. 2000 Mar;20(5):1797-815
10669755
Electrophoresis. 2000 Apr;21(6):1054-70
10786880
BMC Genomics. 2003 Jul 29;4(1):31
12885301
Science. 1995 Oct 20;270(5235):484-7
7570003
J Neurochem. 2004 Apr;89(1):73-89
15030391
Rheumatology (Oxford). 2002 Jun;41(6):605-18
12048286
Cancer Res. 2003 Apr 15;63(8):1865-70
12702575
J Neuropathol Exp Neurol. 2002 Jul;61(7):597-604
12125738
J Cell Biol. 1999 Oct 4;147(1):185-94
10508865
Genome Res. 2000 Nov;10(11):1796-806
11076864
Mol Psychiatry. 2003 Oct;8(10):863-78
14515137
Science. 2001 Feb 16;291(5507):1304-51
11181995
J Neurochem. 1998 May;70(5):1781-92
9572261
Epilepsia. 2001 Dec;42(12):1501-6
11879359
Nature. 2001 Feb 15;409(6822):860-921
11237011
J Cereb Blood Flow Metab. 2001 Jan;21(1):61-8
11149669
Neurosurgery. 2004 Feb;54(2):410-23; discussion 423-5
14744289
J Biol Chem. 1999 Jan 8;274(2):728-34
9873008
J Cereb Blood Flow Metab. 2000 Jul;20(7):1096-102
10908043
J Cell Biol. 2003 May 12;161(3):653-60
12743111
CNS Drugs. 2001;15(8):597-607
11524032
J Cereb Blood Flow Metab. 2002 Mar;22(3):245-52
11891429